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Nonconservative mutations were introduced by site-specific mutagenesis into the fusion peptide and the
adjacent heptad repeat region of the fusion protein of Newcastle disease virus in order to determine the role
of both regions in the fusion activity of the protein. Mutations in both regions that allowed for proper folding
and intracellular transport of the protein blocked the fusion activity of the protein when assayed in the
presence of the hemagglutinin-neuraminidase protein.
Membrane fusion, central to the entry of enveloped viruses,
is mediated by one or more viral glycoproteins. Most of these
fusion proteins have a conserved hydrophobic or apolar se-
quence, termed a fusion peptide or sequence, thought to be
directly involved in the fusion event (28). As initially pointed
out by Chambers et al. (3), many fusion proteins also have one
or more heptad repeat regions which are often adjacent to the
fusion sequence. The role of these regions in fusion is ill-
defined.
Membrane fusion mediated by paramyxoviruses, such as
Newcastle disease virus (NDV), usually requires two glyco-
proteins, the attachment protein (hemagglutinin-neuramini-
dase [HN] protein) and the fusion protein (F) (8, 9, 14). While
the HN protein mediates attachment and has a yet-undefined
role in subsequent membrane fusion (9, 23), the fusion protein
is thought to be directly involved in the fusion event (9, 28).
This protein is synthesized as a precursor (FO) which is
activated upon proteolytic cleavage to produce a disulfide-
linked F1 and F2 (19, 20). The fusion peptide is at the new
amino terminus of F1 generated by the cleavage, and the
heptad repeat is adjacent to the fusion peptide.
Mutational analysis of the paramyxovirus simian virus 5
fusion peptide showed that conservative mutations that al-
lowed intracellular transport of the protein either had no effect
on fusion or enhanced the fusion activity of the protein (7).
There has been no reported mutational analysis of the adjacent
heptad repeat region of a paramyxovirus fusion protein.
Expression of fusion proteins with nonconservative muta-
tions in the fusion peptide or heptad repeat. Figure 1A shows
the amino acid sequence of the fusion peptide and adjacent
heptad repeat region of the NDV F1 protein aligned with the
comparable sequences from the fusion proteins of other
representative paramyxoviruses. Point mutations resulting in
single amino acid changes (Fig. 1B) were introduced into both
regions of the protein by site-specific mutagenesis as previously
described (10). The heptad repeat is predicted to form an
helix (3), as is the adjacent fusion peptide (18, 24). Figure 1C
shows the entire region as an a helix with the position of the
mutations indicated. Most of the mutations introduced were
located on the hydrophobic or apolar side of the helix in the a
or d position.
* Corresponding author. Mailing address: Department of Molecular
Genetics and Microbiology, University of Massachusetts Medical
School, 55 Lake Ave. North, Worcester, MA 01655. Phone: (508)
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The mutant proteins were expressed in Cos 7 cells by using
simian virus 40-based vector as previously described (10, 23).
Cells transfected with wild-type and mutant fusion protein
genes were radioactively labeled with [35S]methionine for 2 h
at 48 h posttransfection, and labeled protein was precipitated
with anti-Fula (Fig. 2A and B), a monoclonal antibody which
reacts only with mature folded fusion protein (16). Precipitated
proteins were electrophoresed in the absence (Fig. 2A, lanes 1
through 12, and 2B, lanes 1 through 8) or presence (Fig. 2A,
lanes 13 through 24, and 2B, lanes 9 through 16) of reducing
agent. In the absence of reducing agent, the uncleaved Fo and
cleaved but disulfide-linked F1 and F2 comigrate as a single
band with an approximate molecular weight of 70,000 (Fnr),
while in the presence of reducing agent, Fo and F1 are resolved.
F2 is not detected under these conditions (12, 17).
Mutant proteins A130K (resulting from an A-to-K mutation
at position 130), A140K, N147K (Fig. 2A), G119K, A126K,
A133K, and L154K (Fig. 2B) were precipitated by anti-Fula,
TABLE 1. Quantitation of expression and activities of fusion
protein mutants
Surface Fusion
expression' activityb
Wild type 100 100
G119K 87 1
G123K 216 11
A126K 551 3
G128L 0 9
A130K 277 14
A133K 129 6
A140K 80 8
N147K 79 14
1151K 0 9
L154K 96 6
K155L 0 8
1158K 0 3
a Surface expression was quantitated as previously described (9, 10, 21). The
values obtained for the wild type were set at 100%, and the values obtained for
mutant proteins are expressed as percentages of the wild-type value. Values are
averages for three separate experiments.
b Fusion activity was determined as previously described (21). The average size
of syncytia obtained at 48 h with the wild-type fusion protein gene was set at
100%, and the values obtained for the mutant proteins are expressed as
percentages of the wild-type value. Values are averages for three separate
experiments.
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FIG. 1. Location of mutations in the fusion sequ
repeat region. (A) The sequence at the amino termi
(strain AV) F1 protein is shown aligned with compa
from representative paramyxovirus F1 proteins (5, 13)
at the F1 amino terminus is residue 117 in the entire
fusion protein of NDV. The solid bar above the seque
sequence defined as the region of sequence hom(
family. The heptad repeat is the region just carboxy
fusion peptide. MuV, mumps virus; SV5, simian vin
virus; PIV3, parainfluenza virus 3; MV, measles
positions of mutations are shown on the NDV se
pointing upward indicate mutations that result in r
transported to the cell surface, while arrows poi
indicate changes that block transport (see text).
sequence and the heptad repeat region of the ND)
represented as an a helix beginning with the amino-
alanine (F) in position b and the hydrophobic side
positions a and d. The positions of each of the 12 mu
here on the helix are represented by an arrow. Soli(
changes that result in proteins that are transported to
while open letters indicate changes that result in prol
transported. Boxed letters indicate changes reportec
(27).
reeat while G128L,I151K, K155L, 1158K (Fig. 2A), and G123K (Fig.2B) were not precipitated. With the exception of L154K, all
precipitated proteins appeared to be cleaved as efficiently as
KESITATNEAVHEV the wild type, since F1 was detected in at least wild-type
MKNSIQ,TNRAIEV amounts.
IKNAADV In an attempt to detect other mutant proteins, extracts were
KESMf'rHKSIEL also precipitated with anti-NDV antiserum. The anti-F anti-
KEAIRDTNKVS bodies in this serum also only recognize mature protein, not
PASLETn4=IE nascent protein (23). Like anti-Fula, anti-NDV antiserum did
not precipitate G128L, I151K, K155L, and 1158K mutant
proteins (data not shown), a result that suggests that these
mutant proteins are not properly folded. However, this serum
did precipitate G123K, and the precipitated protein contained
as much F1 as the wild type did (Fig. 2C, lane 6). In addition,
54 this serum precipitated F1 in the L154K precipitate (Fig. 2C,
K lane 9).
t In order to detect mutant proteins not reactive to confor-
LKESIMTEAWEV mation-sensitive antibodies, the expression of the mutant
4 proteins was further characterized by Western blot (immuno-
L K blot) analysis with a polyclonal serum raised against a peptide
L55 158 with the sequence of the cytoplasmic tail of the fusion protein
(27). Preliminary results with this antibody showed that, while
reactivity of this antibody to wild-type protein on Western blots
was low if the protein was boiled prior to electrophoresis (data
not shown), proteins incubated at room temperature or heated
to 50°C were readily detected. Furthermore, under these
conditions, the antibody detected the cleaved F1 and the
uncleaved Fo, as well as larger oligomeric forms that were
resistant to sodium dodecyl sulfate (SDS) as previously re-
ported by Taylor et al. (25). In virion preparations, in the
absence of reducing agent, three sizes of molecules were
IALQLAKNTAQ detected, a monomer-sized species (Fnr) and two larger spe-
+ cies (140,000 and 210,000 kDa) which likely represent SDS-
L155 resistant oligomeric forms, while the monomer (F1 and FO) and
FSTANLTHSG a 140,000-kDa species are seen in the presence of reducing
agent. Transfected cells also contained monomers as well as
heterogeneous, higher-molecular-weight material which elec-
trophoresed with molecular weights of approximately 140,000
and higher.
Western analysis detected the expression of G128L, 1151K,
K155L, and 1158K mutant proteins which had not been
detected in immunoprecipitations. As expected, only the Fo
forms of these mutant proteins were detected (Fig. 3A, lanes
14 and 18 through 20). The absence of cleavage of these
mutants is a result consistent with failure to acquire mature
ence and heptad epitopes recognized by the conformation-sensitive antibodies
inus of the NDV and strongly suggests that these mutant proteins are not
arable sequences transported to the cell surface. Western analysis of other
The amino acid mutant proteins confirmed the cleavage of mutant proteins
sequence of the A140K, N147K, G119K, G123K, A133K, and L154K, although
celogy across the the amount of F1 detected in the L154K and G123K protein
oterminal to the populations was less than the wild-type amount. Mutant pro-
us 5; SV, Sendai teins G128L, A130K, and A126K electrophoresed primarily as
virus. (B) The SDS-resistant oligomers (Fig. 3A, lanes 14 and 15, and 3B, lane
-quence. Arrows 14), in contrast to the wild-type protein, suggesting that these
)roteins that are mutations increased the SDS-resistant interactions of the
nting downward proteins in oligomeric structures.
(C) The fusion Surface expression of mutant proteins. To determine which
V F1 protein are mutant proteins were transported to the cell surface, immuno-
terminal phenyl- fluorescence was performed on intact cells transfected with
utations reported wild-type and mutant proteins as previously described (11).
d letters indicate Figure 4 shows that all mutant proteins that could be detected
) the cell surface, by immunoprecipitations with conformation-specific antibod-
teins that are not ies were detected at the cell surface (G119K, G123K, A126K,
d by Wang et al. A130K, A133K, A140K, N147K, and L154K). Mutant proteins
not reactive to conformationally sensitive antibodies (G128L,
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FIG. 2. Immunoprecipitation of mutant proteins with conformation-sensitive antibodies. At 48 h posttransfection by using DEAE-dextran, cells
were radioactively labeled with [35S]methionine for 3 h and lysed as previously described (23). Proteins present in extracts from 4 x 105 cells were
precipitated with anti-Fula (A and B) or anti-NDV (C), and the precipitated protein was electrophoresed in the presence or absence of reducing
agent. (A) Lanes: 1 to 12, nonreduced; 13 to 24, reduced. (B) Lanes: 1 to 8, nonreduced; 9 to 16, reduced. (C) All lanes contain reduced protein.
V, virus-infected cells not immunoprecipitated; SVL, vector; wt, wild type. Mutants are indicated at the top of each lane. Lanes 4 and 16 in panel
A, 3 and 11 in panel B, and 4 in panel C show precipitated proteins in wild-type-transfected extracts in the absence of antibody. F(, uncleaved fusion
protein; F1, cleavage product; Fnr, cleaved and uncleaved fusion proteins which comigrate under nonreducing conditions.
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1151K, K155L, and 1158K) were not detected. All proteins
detected at the surface were in either the a or d position in the
cx helix (Fig. 1C, solid letters), while the four mutants not
transported to the surface were in various other positions on
-zoo kd the helix (Fig. 1C, open letters). Interestingly, two mutations
previously reported in this region are in the g and c positions
on the helix (Fig. 1C, boxed letters) and result in proteins that
-97 kd are temperature sensitive in folding (27).
The surface expression of mutants was quantitated as pre-
-69 kd viously described (15) (Table 1). All mutant proteins detected
at the cell surface were present at approximately wild-type or
higher levels. Some mutant proteins, particularly A126K and
- 200 kd.
97 kd~~~~~~~~~~~~~~~~~~~F
F ,m 9d.
n-F,j
4 5 e-1 "A 4
FIG. 3. Western analysis of mutant proteins. At 48 h posttransfec-
tion, cells were lysed and proteins present were subjected to electro-
phoresis on 6% polyacrylamide gels. Prior to electrophoresis, extracts
were incubated in gel sample buffer (23) at room temperature for 10
min. Proteins in lanes 1 to 10 in panel A and lanes 1 to 8 in panel B
were electrophoresed in the absence of reducing agent; proteins in
lanes 11 to 20 in panel A and lanes 9 to 16 in panel B were
electrophoresed in the presence of reducing agent. Proteins were
detected by Western analysis with anti-Flaji antibody (27). Positions of
marker proteins are indicated at the side of the autoradiograph. V,
virus proteins; SVL, vector; wt, wild type. Mutants are indicated at the
top of the lanes. Fo, uncleaved fusion protein; Fl, cleavage product;
Fnr, cleaved and uncleaved fusion proteins which comigrate under
nonreducing conditions.
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FIG. 4. Immunofluorescent detection of cell surface mutant proteins. At 48 h posttransfection, cells transfected with wild-type DNA (A) and
mutant DNAs (B to M) were prepared for immunofluorescent detection of surface protein (10). Film was exposed for the same length of time for
each panel. Panels: B, G119K; C, G123K; D, A126K, E, G128L; F, A130K; G, A133K; H, A140K; I, N147K; J, I151K; K, L154K; L, K155L; M, I158K
A13OK, were expressed at much higher levels than that of the
wild type. The mechanism involved in this increased expression
is now under active investigation.
Fusion activity of mutant proteins. As is typical of many
paramyxovirus fusion proteins (8, 9, 14, 23), the NDV fusion
protein does not direct membrane fusion unless coexpressed
with the HN protein. Thus, to measure the fusion activity of
the mutants, Cos cells were cotransfected with the mutant
fusion protein genes as well as the wild-type HN protein gene.
The size of syncytia formed with time after transfection was
quantitated as previously described (23), and the results are
shown in Table 1.
Clearly, nonconservative changes in the fusion peptide
which did not block folding and transport eliminated fusion
activity. The failure of these mutants to direct membrane
fusion is likely due to direct effects on the insertion of the
fusion peptide into membranes. It has been proposed that in
several systems, the fusion peptide mediates membrane fusion
by inserting obliquely into an adjacent membrane (6, 26). Thus,
mutational changes which can block insertion or change the
angle of insertion affect the fusion activity of the protein (26).
Insertion of a charge would likely prohibit the insertion of this
region of the protein into adjacent membranes just as insertion
of a charge into the fusion peptide of the retrovirus transmem-
brane protein blocks fusion (1).
While introduction of a charged residue in several locations
in the a position of the heptad repeat blocks transport, all
mutants in the d position were transported to the cell surface.
These mutations also block fusion. Several possible mecha-
nisms may be envisioned. First, heptad repeats are character-
istic of regions of molecules which form coiled-coil oligomeric
structures (4, 21). We have found that these mutations do not
block the formation of oligomers (unpublished data). How-
ever, a charge may disrupt a localized coiled-coil structure that
might be required for fusion. Alternatively, alteration of this
region of the fusion protein sequence may inhibit the activa-
tion of the fusion protein. The NDV fusion protein requires
the presence of the HN protein to mediate membrane fusion.
It has been hypothesized that the HN protein activates the F
protein (2, 9, 23) in much the same way that acid pH activates
the HA protein of influenza virus (2, 28-30) by changing the
conformation of the fusion sequence and adjacent heptad
repeat region. The introduction of nonconservative, charged
amino acids into this region of the molecule may block this
activation by interfering with a conformational change induced
by the HN protein. Another possible mechanism is that this
region of the fusion protein may also insert into membranes.
Amphipathic a helixes can lie sideways along membranes with
the side chains of the amino acids on the hydrophobic face
penetrating the bilayer (22). Such an interaction of regions of
VOL. 68, 1994
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the fusion protein with the adjacent membrane, in addition to
insertion of the fusion peptide into membranes, may be
required in the fusion process, and introduction of a charge
would block such an interaction.
In summary, nonconservative mutations along one side of a
predicted ao helix in both the fusion peptide and the adjacent
heptad repeat region of the NDV fusion protein block its
fusion activity.
This work was supported by grants AI30572 and GM 37745 from the
National Institutes of Health.
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